Nowadays, the diagnosis and treatment system of malignant tumors has increasingly tended
to be more precise and personalized. And the existing tumor models are still unable to fully …

Castration-resistant prostate cancer, or CRPC, is an aggressive stage of prostate cancer
(PCa) in which PCa cells invade nearby or other parts of the body. When a patient with PCa …

In an attempt to identify small molecules for targeted therapy of non-small cell lung
carcinoma (NSCLC) and prostate cancer (PCa), new arylidene indanones (1–10) were …

Background As the second most common cancer in men and the leading cause of cancer‐
related death, prostate cancer (PCa) could potentially be treated by inducing ferroptosis. In …

Pancreatic cancer is the leading cause of cancer mortality worldwide. Research
investigating effective management strategies for pancreatic cancer is ongoing. Vitamin E …

Small interfering RNAs (siRNA) technology has emerged as a promising therapeutic tool for
human health conditions like cancer due to its ability to regulate gene silencing. Despite …

The natural extracellular matrix (ECM) consists of a continuous integrated fibrin network and
a negatively charged proteoglycan-based matrix. In this work, we report a novel three …

Prostate cancer (PCa) is a significant health concern for men worldwide and is particularly
prevalent in the United States. It is a complex disease presenting different molecular …

Immune cells play a critical role in the defense mechanisms for human health. However,
they can also catalyze tumorigenesis, and cancer progression (1). Consequently, cancer …

Background Increasing evidence indicates that cancer stem cells (CSCs) and cancer stem-
like cells form a special subpopulation of cells that are ubiquitous in tumors. These cells …